Table 1.
Clinical characteristics of the two patient groups
| Group A | Group B | |
|---|---|---|
| (SK-treated subjects) | (Control subjects) | |
| Women/men | 2/5 | 2/5 |
| Age (years) | 55·14 ± 2·71 | 59·14 ± 4·18 |
| Infarct location, n | ||
| Anterior | 4/7 | 4/7 |
| Inferior | 3/7 | 3/7 |
| Infarct related artery, n | ||
| LAD | 6/7 | 4/7 |
| LCx | 2/7 | 1/7 |
| RCA | 2/7 | 5/7 |
| Killip scale >2, n | 0/7 | 0/7 |
| Myocardial enzymes (peak) | ||
| CPK, U/L | 3342 ± 760 | 2991 ± 1008 |
| CPK-MB, U/L | 257 ± 154 | 300 ± 237 |
| AST, U/L | 297 ± 194 | 315 ± 250 |
LAD, left anterior descending coronary artery; LCx, left circumflex coronary artery; and RCA, right coronary artery. The χ2 test or Student's t-test was applied where appropriate. No indication is given where the statistics were not significant.